Brief: UniQure Provides Regulatory Update On Amt-130 For Huntington’S Disease
02/06/2025 13:21
June 2 (Reuters) - UNIQURE PROVIDES REGULATORY UPDATE ON AMT-130 FOR HUNTINGTON’S DISEASE UNIQURE NV - EXPECTS BLA SUBMISSION FOR AMT-130 IN Q1 2026 UNIQURE NV - FDA AGREES ON AMT-130 MANUFACTURING PROCESS VALIDATION Source text: ID:nGNX7GvFH3 ((Reuters.Briefs@thomsonreuters.com;))
Recent news on uniQure
See all newsuniQure tumbles after updated Huntington's disease gene therapy data
UniQure plunges as Huntington's trial data disappoints investors (updated)
uniQure tumbles after updated Huntington's disease gene therapy data
UniQure's Huntington's therapy fails to significantly slow disease progression in trial
uniQure seeks US approval for Huntington's gene therapy after FDA reversal